연구성과로 돌아가기
JCR 2024 저널 목록 (539 / 2104)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Journal Name | Publisher | ISSN | eISSN | Edition | WoS Category | Total Citation | JIF | JIF Quartile | 상위 JCR(%) | JIF % | JIF Rank | 5-Year JIF | 5-Year Quartile | JIF w/o Self-Cites | Immediacy Index | JCI | JCI Rank | JCI Quartile | JCI Percentile | Eigenfactor Score | Normalized Eigenfactor | Article Influence Score | AIS Quartile | Citable Items | Articles in Citable Items (%) | Cited Half-Life | Citing Half-Life | Total Articles | Citable OA (%) | 수집시기 | 바로가기 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Journal of Semiconductors | IOP Publishing Ltd | 1674-4926 | 1674-4926 | ESCI | PHYSICS, CONDENSED MATTER | 3,971 | 5.3 | Q2 | 27.2 | 72.8 | 22/79 | 4.4 | Q2 | 5.0 | 1.0 | 0.56 | 29/79 | Q2 | 63.92 | 0.004 | 0.869 | 0.834 | Q2 | 126 | 78.6% | 4.2 | 5.7 | 99 | 1.4% | 2025-08-05 16:04:40 | 바로가기 |
| JOURNAL OF SLEEP RESEARCH | WILEY | 0962-1105 | 1365-2869 | SCIE | NEUROSCIENCES | 9,817 | 3.9 | Q2 | 27.2 | 72.8 | 86/314 | 3.8 | Q2 | 3.6 | 0.5 | 0.94 | 107/314 | Q2 | 66.08 | 0.011 | 2.362 | 1.133 | Q2 | 285 | 84.6% | 6.6 | 8.7 | 241 | 53.9% | 2025-08-05 16:04:18 | 바로가기 |
| JOURNAL OF SOCIAL POLICY | CAMBRIDGE UNIV PRESS | 0047-2794 | 1469-7823 | SSCI | PUBLIC ADMINISTRATION | 2,536 | 2.6 | Q2 | 27.2 | 72.8 | 25/90 | 2.8 | Q2 | 2.2 | 0.4 | 1.06 | 29/90 | Q2 | 68.33 | 0.002 | 0.520 | 0.921 | Q2 | 39 | 100.0% | 8.6 | 6.8 | 39 | 67.5% | 2025-08-05 16:04:58 | 바로가기 |
| Journal of the Academy of Nutrition and Dietetics | ELSEVIER SCIENCE INC | 2212-2672 | 2212-2680 | SCIE | NUTRITION & DIETETICS | 8,322 | 4.0 | Q2 | 27.2 | 72.8 | 31/112 | 4.6 | Q2 | 3.8 | 1.1 | 0.81 | 39/112 | Q2 | 65.63 | 0.007 | 1.543 | 1.312 | Q1 | 103 | 92.2% | 6.8 | 7.9 | 95 | 17.7% | 2025-08-05 16:04:21 | 바로가기 |
| Nature and Science of Sleep | DOVE MEDICAL PRESS LTD | 1179-1608 | 1179-1608 | SCIE | CLINICAL NEUROLOGY | 3,245 | 3.4 | Q2 | 27.2 | 72.8 | 78/285 | 3.5 | Q2 | 3.2 | 0.4 | 0.87 | 100/285 | Q2 | 65.09 | 0.005 | 1.042 | 1.000 | Q2 | 171 | 93.0% | 4.1 | 6.3 | 159 | 99.1% | 2025-08-05 16:02:42 | 바로가기 |
| Neurodegenerative Disease Management | TAYLOR & FRANCIS LTD | 1758-2024 | 1758-2032 | ESCI | CLINICAL NEUROLOGY | 966 | 3.4 | Q2 | 27.2 | 72.8 | 78/285 | 3.3 | Q2 | 3.1 | 0.5 | 0.67 | 161/285 | Q3 | 43.68 | 0.001 | 0.220 | 0.877 | Q2 | 25 | 68.0% | 6.0 | 8.0 | 17 | 52.1% | 2025-08-05 16:02:43 | 바로가기 |
| NEUROMOLECULAR MEDICINE | HUMANA PRESS INC | 1535-1084 | 1559-1174 | SCIE | NEUROSCIENCES | 2,555 | 3.9 | Q2 | 27.2 | 72.8 | 86/314 | 4.2 | Q2 | 3.8 | 0.5 | 0.81 | 140/314 | Q2 | 55.57 | 0.002 | 0.400 | 0.939 | Q3 | 54 | 81.5% | 8.0 | 7.3 | 44 | 22.5% | 2025-08-05 16:04:19 | 바로가기 |
| NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY | WILEY | 0305-1846 | 1365-2990 | SCIE | CLINICAL NEUROLOGY | 4,312 | 3.4 | Q2 | 27.2 | 72.8 | 78/285 | 4.1 | Q2 | 3.3 | 0.7 | 1.05 | 66/285 | Q1 | 77.02 | 0.004 | 0.852 | 1.499 | Q1 | 55 | 87.3% | 9.6 | 8.5 | 48 | 63.8% | 2025-08-05 16:02:42 | 바로가기 |
| NEUROSCIENTIST | SAGE PUBLICATIONS INC | 1073-8584 | 1089-4098 | SCIE | NEUROSCIENCES | 5,560 | 3.9 | Q2 | 27.2 | 72.8 | 86/314 | 5.8 | Q1 | 3.9 | 1.1 | 0.73 | 175/314 | Q3 | 44.43 | 0.003 | 0.755 | 1.844 | Q1 | 34 | 38.2% | 10.7 | 10.0 | 13 | 24.8% | 2025-08-05 16:04:18 | 바로가기 |
| NEUROTOXICOLOGY | ELSEVIER | 0161-813X | 1872-9711 | SCIE | NEUROSCIENCES | 7,988 | 3.9 | Q2 | 27.2 | 72.8 | 86/314 | 4.1 | Q2 | 3.8 | 0.6 | 1.03 | 87/314 | Q2 | 72.45 | 0.005 | 1.030 | 0.854 | Q3 | 97 | 88.7% | 8.3 | 8.6 | 86 | 16.3% | 2025-08-05 16:04:18 | 바로가기 |
| Pain Practice | WILEY | 1530-7085 | 1533-2500 | SCIE | ANESTHESIOLOGY | 3,520 | 2.7 | Q2 | 27.2 | 72.8 | 19/68 | 2.8 | Q2 | 2.5 | 0.5 | 0.79 | 27/68 | Q2 | 61.03 | 0.003 | 0.659 | 0.798 | Q2 | 79 | 82.3% | 7.3 | 7.5 | 65 | 36.1% | 2025-08-05 16:02:26 | 바로가기 |
| PARKINSONISM & RELATED DISORDERS | ELSEVIER SCI LTD | 1353-8020 | 1873-5126 | SCIE | CLINICAL NEUROLOGY | 13,126 | 3.4 | Q2 | 27.2 | 72.8 | 78/285 | 3.8 | Q2 | 3.2 | 1.0 | 0.95 | 82/285 | Q2 | 71.40 | 0.012 | 2.723 | 1.188 | Q2 | 243 | 87.2% | 7.6 | 7.1 | 212 | 20.6% | 2025-08-05 16:02:42 | 바로가기 |
| Policy Design and Practice | TAYLOR & FRANCIS LTD | N/A | 2574-1292 | ESCI | PUBLIC ADMINISTRATION | 772 | 2.6 | Q2 | 27.2 | 72.8 | 25/90 | 4.9 | Q1 | 2.5 | 1.2 | 1.47 | 14/90 | Q1 | 85.00 | 0.002 | 0.335 | 1.392 | Q1 | 22 | 100.0% | 4.1 | 5.6 | 22 | 96.2% | 2025-08-05 16:04:58 | 바로가기 |
| PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY | PERGAMON-ELSEVIER SCIENCE LTD | 0278-5846 | 1878-4216 | SCIE | NEUROSCIENCES | 14,304 | 3.9 | Q2 | 27.2 | 72.8 | 86/314 | 4.8 | Q1 | 3.7 | 0.7 | 1.41 | 41/314 | Q1 | 87.10 | 0.012 | 2.655 | 1.293 | Q2 | 261 | 94.2% | 7.1 | 8.5 | 246 | 21.0% | 2025-08-05 16:04:18 | 바로가기 |
| PUBLIC PERSONNEL MANAGEMENT | SAGE PUBLICATIONS INC | 0091-0260 | 1945-7421 | SSCI | PUBLIC ADMINISTRATION | 1,276 | 2.6 | Q2 | 27.2 | 72.8 | 25/90 | 3.1 | Q2 | 2.4 | 0.3 | 1.10 | 25/90 | Q2 | 72.78 | 0.001 | 0.171 | 0.718 | Q2 | 24 | 100.0% | 9.5 | 10.0 | 24 | 21.6% | 2025-08-05 16:04:58 | 바로가기 |
페이지 이동: